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not affected. Moreover, when subjected to transaortic constriction 
(TAC), TGMHCJ1 mice demonstrated an impaired LV hypertrophic 
response to pressure overload and reduced cardiac  brosis. These 
results indicate that chronic activation of Notch affects differently 
left and right ventricle integrity under physiological and pathological 
conditions.
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VASCULAR SMOOTH MUSCLE MODULATES 
ENDOTHELIAL CONTROL OF VASOREACTIVITY VIA 
ROS PRODUCTION THROUGH MYOENDOTHELIAL 
COMMUNICATIONS
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Endothelial control of vascular smooth muscle plays a major 
role in the resulting vasoreactivity implicated in physiological or 
pathological circulatory processes. However, a comprehensive 
understanding of endothelial (EC) / smooth muscle cells (SMC) 
crosstalk is far from complete. Here, we have examined the role 
of gap junctions in this crosstalk and we demonstrate an active 
contribution of SMC to endothelial control of vasomotor tone.
In small intrapulmonary arteries, quantitative RT-PCR, Western 
Blot analyses revealed the presence of 3 connexins (Cx): 37, 40 and 
43. Immuno uorescence labelling showed the presence of Cx 37, 
40 and 43 in EC and the presence of Cx 37 and 40 in SMC. Functional 
experiments showed that the peptides homologous to the gap 26 
and 27 domains of the extracellular loops of Cx 43 (43Gap 26) or 
Cx 37 and 43 (37-43Gap 27) respectively, (1) interrupt intercellular 
communications in a speci c manner, (2) attenuate the calcium 
and contractile responses to serotonin (5-HT) simultaneously 
recorded in pulmonary arteries and (3) abolish the diffusion in SMC 
of carboxy uorescein-AM loaded in EC. Similarly, contractile and 
calcium responses to 5-HT were decreased by superoxide dismutase 
and catalase which, catabolize superoxide anion (O2•-) and H2O2, 
respectively. Both Cx- and reactive oxygen species (ROS)-mediated 
effects on the responses to 5-HT were reversed by (1) L-NAME, 
a NO synthase inhibitor, or (2) endothelium removal with CHAPS. 
Electron paramagnetic resonance directly demonstrated that 5-HT-
induced ROS production, and more speci cally O2•-, originated 
from the SMC. Finally, 5-HT decreased basal cyclic GMP content 
in isolated intact arteries, whereas a cocktail of 5-HT, superoxide 
dismutase and catalase increased basal cyclic GMP content.
Altogether, the  ndings suggest that 5-HT produces O2•- in the 
smooth muscle and NO in the endothelium. O2•- passes through the 
myoendothelial junctions to decrease endothelial NO production 
and thus strengthen pulmonary vasoreactivity. This is the  rst time 
that we demonstrate a control of the endothelial NO function by the 
smooth muscle is demonstrated. Since ROS is often overproduced in 
many cardiovascular diseases, such process could also be of great 
importance in pathological conditions.
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EFFETS DES CONTRAINTES MÉCANIQUES SUR 
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L’expression de l’intégrine αvβ3 pourrait jouer un rôle dans le tonus 
vasomoteur et le remodelage de la paroi vasculaire. Nous avons 
examiné l’effet des contraintes mécaniques sur l’expression de cette 
intégrine et l’apoptose des cellules musculaires lisses vasculaires 
(CML) en relation avec leur capacité à générer la thrombine. Nous 
avons utilisé un modèle de cultures primaires de CML d’aorte de rat 
Wistar soumis à des contraintes pulsatiles avec un appareil de type 
Flexercell (1 Hz, 10 % d’élongation, dans un milieu à 0.5 % de sérum 
de veau fœtal). L’ARNm de la sous-unité αV est augmenté après 1 h 
d’exposition aux contraintes mécaniques et celui de la sous-unité β3 
après 3 h. Cela s’accompagne dés la 30e min d’une augmentation 
de l’expression des marqueurs de différenciation (chaîne lourde de 
la myosine, sm-actine et smootheline) d’un facteur 2. Au niveau 
protéique, l’augmentation de l’intégrine αvβ3 et des marqueurs de 
différenciation est observée à partir de 24 h, et la phosphorylation des 
molécules p38, FAK et ERK à 48 h. Une réponse apoptotique, quanti ée 
par l’expression de phospholipides procoagulants à la surface des CML, 
survient dès 5 min. La concentration en thrombine active mesurée 
par thrombinographie in vitro est augmentée d’un facteur 1.7 par 
les contraintes mécaniques. L’intégrine αvβ3 étant le récepteur de 
la prothrombine au niveau des CML, nous avons étudié l’effet d’un 
anticorps fonctionnel anti-αVβ3. A l’état basal, la concentration 
maximale en thrombine par les CML est diminuée en présence de cet 
anticorps. En conclusion, l’augmentation d’expression de l’intégrine 
αvβ3 et de l’exposition de phospholipides anioniques à la surface 
externe des membranes en réponse aux contraintes mécaniques 
pourrait expliquer l’augmentation de thrombine par les CML.
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Thrombomodulin is a transmembrane proteoglycan with an 
ectodomain released in blood. Known as the thrombin-cofactor 
to inhibit coagulation, thrombomodulin has also a key role in 
 brinolysis, development, cellular proliferation and in ammation. 
We previously demonstrated that the endothelial thrombomodulin 
has a speci c signalling pathway and mediates Epidermal Growth 
Factor Receptor (EGFR) transactivation. Here, we explored the 
hypothesis that soluble thrombomodulin, which contains the 
N-terminal lectin C-like region and 6 EGF -like domains mediates 
the EGFR transactivation by thrombin.
Human endothelial cells were incubated with either thrombin to 
activate both thrombomodulin and PAR-1, or a mutant thrombin 
that is unable to activate PAR-1, or a recombinant soluble 
thrombomodulin. The EGFR tyrosine kinase was inhibited by 
